Vivitrol Powder For Suspension For Injection, Extended Release 380Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Vivitrol: Powder for suspension for injection, Extended Release (380mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

NALTREXONE (nal TREX one) is used to treat certain types of drug dependence.

In-Depth Information

Vivitrol 380mg Powder for Injection

NDC: 634590300
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Ethanol Dependence, Opiate Agonist Dependence

Storage Information
Refrigerate (between 36 and 46 degrees F)
Do not expose product to temperatures above 77 degrees F
Unrefrigerated product can be stored at temperatures not exceeding 77 degrees F for no more than 7 days prior to administration
Protect from freezing
Vivitrol 380mg Powder for Injection

Reported Side Effects for Vivitrol 380mg Powder for Injection

Irritability Incidence:
<10.0%*
Severity: MILD
Onset: DELAYED
Injection Site Reaction Incidence:
<69.0%*
Severity: MILD
Onset: RAPID
Hoarseness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Hallucinations Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Confusion Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Chills Incidence:
<10.0%*
Severity: MILD
Onset: RAPID
Blurred Vision Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Causing To Be Hungry Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Fainting Incidence:
<13.0%*
Severity: MILD
Onset: EARLY
Yawning Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Weight Loss Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Weight Gain Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Rapid Heart Rate Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Restlessness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
<10.0%*
Severity: MILD
Onset: EARLY
Excessive Thirst Incidence:
<10.0%*
Severity: MILD
Onset: EARLY
Irritated Blood Vessels Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Stomach Ulcer Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Paranoia Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Ear Pain Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Eye Irritation Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Nightmares Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Decreased Sexual Desire Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Hot Flashes Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Hemorrhoids Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Gas Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Fever Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Nose Bleed Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Swelling Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Painful Urination Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Shortness Of Breath Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Drowsiness Incidence:
<4.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
<13.0%*
Severity: MILD
Onset: EARLY
Cough Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Constipation Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
<14.0%*
Severity: MILD
Onset: EARLY
Dry Mouth Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Shaking Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Ringing In Ears Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Sneezing Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Runny Nose Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
High Blood Pressure Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Stuffy Nose Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Eye Inflammation Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Light Sensitivity Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Nervousness Incidence:
2.0-12.0%*
Severity: MILD
Onset: DELAYED
Vomiting Incidence:
3.0-14.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
3.0-25.0%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
3.0-14.0%*
Severity: MILD
Onset: EARLY
Tooth Pain Incidence:
4.0%*
Severity: MILD
Onset: DELAYED
Tired Incidence:
>4.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
4.0-13.0%*
Severity: MILD
Onset: EARLY
Back Pain Incidence:
6.0%*
Severity: MILD
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
7.0-20.0%*
Severity: MODERATE
Onset: DELAYED
Muscle Cramps Incidence:
8.0%*
Severity: MILD
Onset: DELAYED
Decreased Appetite Incidence:
9.0-14.0%*
Severity: MILD
Onset: DELAYED
Muscle Pain Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Joint Pain Incidence:
>10.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
10.0-33.0%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
23.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Vivitrol

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.